We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $59.6M
1-Year Est. Return 181.61%
This Fund
S&P 500
This Quarter Est. Return
+27.59%
1 Year Est. Return
+181.61%
3 Year Est. Return
+519.89%
5 Year Est. Return
+603.37%
10 Year Est. Return
+6,669.07%
AUM
$59.6M
AUM Growth
-$124M
Cap. Flow
-$135M
Cap. Flow %
-225.95%
Top 10 Hldgs %
65.41%
Holding
66
New
18
Increased
–
Reduced
2
Closed
43

Top Buys

Rank Stock Value
1
GOOGM
Alphabet Inc Depositary Shares Series A Preferred Stock
GOOGM
+$5.02M
2
GOOGN
Alphabet Inc Depositary Shares Series B Preferred Stock
GOOGN
+$5.01M
3
DLR icon
Digital Realty Trust
DLR
+$4.79M
4
SYRE icon
Spyre Therapeutics
SYRE
+$3.65M
5
SMCIP
Super Micro Computer Depositary Shares 7% Series A Preferred Stock
SMCIP
+$2.69M

Top Sells

Rank Stock Value
1
TERN
Terns Pharmaceuticals
TERN
+$15.8M
2
NEE.PRV
NextEra Energy Inc 7.375% Corporate Units
NEE.PRV
+$15.2M
3
MDLN
Medline Inc
MDLN
+$13.3M
4
NRG icon
NRG Energy
NRG
+$12.4M
5
FPS
Forgent Power Solutions
FPS
+$10.2M

Sector Composition

Rank Sector Weight
1 Healthcare 37.05%
2 Communication Services 24.14%
3 Miscellaneous 13.47%
4 Real Estate 10.53%
5 Industrials 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRSP icon
26
CRISPR Therapeutics
CRSP
$5.25B
– –
-50,000
Closed -$2.38M
CYTK icon
27
Cytokinetics
CYTK
$10.6B
– –
-100,000
Closed -$6.59M
ENGN icon
28
enGene Therapeutics
ENGN
$128M
– –
-320,000
Closed -$2.18M
GFS icon
29
GlobalFoundries
GFS
$25.2B
– –
-50,000
Closed -$2.22M
GPCR icon
30
Structure Therapeutics
GPCR
$3.26B
– –
-50,000
Closed -$2.41M
HNRG icon
31
Hallador Energy
HNRG
$797M
– –
-90,000
Closed -$1.47M
KYMR icon
32
Kymera Therapeutics
KYMR
$9.87B
– –
-35,100
Closed -$2.92M
NKTR icon
33
Nektar Therapeutics
NKTR
$2.59B
– –
-100,000
Closed -$7.2M
NRG icon
34
NRG Energy
NRG
$25.1B
– –
-85,000
Closed -$12.4M
NRGV icon
35
Energy Vault
NRGV
$767M
– –
-176,453
Closed -$582K
NVGS icon
36
Navigator Holdings
NVGS
$1.37B
– –
-75,000
Closed -$1.45M
SABS icon
37
SAB Biotherapeutics
SABS
$337M
– –
-500,000
Closed -$1.92M
TERN
38
DELISTED
Terns Pharmaceuticals
TERN
– –
-300,000
Closed -$15.8M
VIR icon
39
Vir Biotechnology
VIR
$1.86B
– –
-100,000
Closed -$896K
ZBIO
40
Zenas BioPharma
ZBIO
$2.16B
– –
-150,000
Closed -$2.93M
INGM
41
Ingram Micro Holding
INGM
$6.59B
– –
-100,000
Closed -$2.33M
FLOC
42
Flowco Holdings
FLOC
$946M
– –
-100,000
Closed -$2.06M
SNDK
43
Sandisk
SNDK
$258B
– –
-5,000
Closed -$3.18M
KKR.PRD
44
KKR & Co 6.25% Series D Preferred Stock
KKR.PRD
$2.44B
– –
-100,000
Closed -$4.02M
AMBQ
45
Ambiq Micro
AMBQ
$1.43B
– –
-103,756
Closed -$2.64M
WYFI
46
WhiteFiber Inc
WYFI
$794M
– –
-80,000
Closed -$953K
FIGR
47
Figure Technology Solutions
FIGR
$8.2B
– –
-76,520
Closed -$2.6M
EVMN
48
Evommune Inc
EVMN
$444M
– –
-179,340
Closed -$4.12M
MDLN
49
Medline Inc
MDLN
$31.1B
– –
-300,000
Closed -$13.3M
BTGO
50
BitGo Holdings
BTGO
$882M
– –
-150,000
Closed -$1.23M
1
2
3

Similar funds

ICM
Irth Capital Management New York $59.9M AUM 24.87% 1-Year Est. Return
AP
AlpInvest Partners Amsterdam, Netherlands $59.9M AUM 0.03% 1-Year Est. Return
GC
Gullane Capital Memphis, Tennessee $59.2M AUM 51.07% 1-Year Est. Return
CPM
Connective Portfolio Management New York $60.1M AUM 88.93% 1-Year Est. Return
WWP
Wise Wealth Partners Phoenix, Arizona $58.8M AUM 18.05% 1-Year Est. Return
CZI
Chan Zuckerberg Initiative Redwood City, California $58.5M AUM 31.79% 1-Year Est. Return
CT
ClearAlpha Technologies Greenwich, Connecticut $58.3M AUM 11.49% 1-Year Est. Return
GCS
Gordian Capital (Singapore) Singapore $58.2M AUM 99.93% 1-Year Est. Return

Monashee Investment Management's Q2 2026 Portfolio in Review

As of Q2 2026, Monashee Investment Management held 66 positions worth $59.6M, down 68% from $184M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Monashee Investment Management withdrew a net $135M in Q2 2026, closing 43 positions and reducing 2 holdings. Its most notable exit was Terns Pharmaceuticals, an estimated $15.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 49% a quarter earlier, followed by Communication Services and Miscellaneous.

Against the trend, Monashee Investment Management opened a new position in Alphabet Inc Depositary Shares Series A Preferred Stock worth $5.09M.

  • Monashee Investment Management's largest Q2 2026 buy was Alphabet Inc Depositary Shares Series A Preferred Stock: 100,000 shares worth $5.09M.
  • Monashee Investment Management's biggest Q2 2026 reduction was Solid Biosciences, cutting an estimated $6.98M.
  • Monashee Investment Management fully exited Terns Pharmaceuticals in Q2 2026, selling an estimated $15.8M.
  • Monashee Investment Management's ten largest holdings make up 65% of its $59.6M portfolio in Q2 2026.
  • Monashee Investment Management opened 18 new positions and closed 43 in Q2 2026.
  • Monashee Investment Management's portfolio value fell 68% quarter-over-quarter to $59.6M.

Based on Monashee Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.